Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer.
Filaci G, Fravega M, Setti M, Traverso P, Millo E, Fenoglio D, Negrini S, Ferrera F, Romagnoli A, Basso M, Contini P, Rizzi M, Ghio M, Benatti U, Damonte G, Ravetti JL, Carmignani G, Zanetti M, Indiveri F. Filaci G, et al. Among authors: setti m. Blood. 2006 Feb 15;107(4):1505-12. doi: 10.1182/blood-2005-01-0258. Epub 2005 Oct 25. Blood. 2006. PMID: 16249379 Free article.
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.
Ansaldi F, Valle L, de Florentiis D, Parodi V, Murdaca G, Bruzzone B, Durando P, Setti M, Icardi G. Ansaldi F, et al. Among authors: setti m. Hum Vaccin Immunother. 2012 Aug;8(8):1048-52. doi: 10.4161/hv.20347. Epub 2012 Aug 1. Hum Vaccin Immunother. 2012. PMID: 22832261 Free PMC article. Clinical Trial.
Blood transfusions with high levels of contaminating soluble HLA-I correlate with levels of soluble CD8 in recipients' plasma; a new control factor in soluble HLA-I-mediated transfusion-modulated immunomodulation?
Ghio M, Contini P, Ubezio G, Ansaldi F, Setti M, Tripodi G. Ghio M, et al. Among authors: setti m. Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s105-8. doi: 10.2450/2012.0199-12. Epub 2012 Dec 21. Blood Transfus. 2014. PMID: 23356971 Free PMC article.
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.
Fenoglio D, Traverso P, Parodi A, Tomasello L, Negrini S, Kalli F, Battaglia F, Ferrera F, Sciallero S, Murdaca G, Setti M, Sobrero A, Boccardo F, Cittadini G, Puppo F, Criscuolo D, Carmignani G, Indiveri F, Filaci G. Fenoglio D, et al. Among authors: setti m. Cancer Immunol Immunother. 2013 Jun;62(6):1041-52. doi: 10.1007/s00262-013-1415-9. Epub 2013 Apr 17. Cancer Immunol Immunother. 2013. PMID: 23591981
160 results